Replies to post #30690 on Ocata Therapeutics Inc fka OCAT

[rocky301]

Now here is some "REALITY",


ACTC has a very good chance to make the $3.00 dollar mark in 6 months

Sure, no doubt the market will value ACT with a cap of approx. 5 Billion..about 9 times that of GERN...and that will take place less than 1/2 way through a safety study with 6 patients. Excellent..

Phase one for safety is completed ,in doing so it also made the blind person see again .

So we are recruiting the blind and our therapeudic cell line will make them see again?...Excellent